Shilpa Medicare share price
You have to be logged in to add this to Watchlist.- ₹337.30(-0.49%)March 11, 2026 15:29:43 PM IST
- NSE
- BSE
- Vol : 749.61 K (NSE + BSE)Last 20 day avg : 352.58 K
Shilpa Medicare is trading -0.49% lower at Rs 337.30 as compared to its last closing price. Shilpa Medicare has been trading in the price range of 348.75 & 334.80. Shilpa Medicare has given 5.45% in this year & 4.67% in the last 5 days. Shilpa Medicare has TTM P/E ratio 41.43 as compared to the sector P/E of 23.45.There are 2 analysts who have initiated coverage on Shilpa Medicare. There are 2 analysts who have given it a strong buy rating & 0.00 analysts have given it a buy rating. 0.00 analysts have given the stock a sell rating.The company posted a net profit of 44.58 Crores in its last quarter.Listed peers of Shilpa Medicare include Sun Pharmaceutical Industries (0.66%), Dr Reddy's Laboratories (0.88%), Cipla (-0.16%).The Mutual Fund holding in Shilpa Medicare was at 5.20% in 31 Dec 2025. The MF holding has increased from the last quarter. The FII holding in Shilpa Medicare was at 10.97% in 31 Dec 2025. The FII holding has increased from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
Updated on Mar 11, 2026, 10:31 PM UTC
- BetaLow volatility0.61Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
- Debt To EquityHigher than industry0.25The debt-to-equity ratio, indicating a company's financial leverage.
- Dividend YieldLower than industry0.15Annual dividends as a percentage of the stock price.
- PEG RatioIndicates overvaluation12.72The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
- P/E-Price-to-earnings ratio based on trailing 12-month earnings
- P/B-The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
|
| ||||
|
| ||||
Names | Technical rating | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | Bullish | 1,824.90 | 0.66 | 4,37,844.32 | 36.24 | 5.77 | 0.92 | 0.50 |
| Dr Reddy's Laboratories | Bullish | 1,325.50 | 0.88 | 1,10,475.41 | 18.63 | 3.14 | 0.63 | 2.34 |
| Cipla | Bearish | 1,331.00 | -0.16 | 1,07,515.61 | 22.95 | 3.87 | 0.87 | 0.81 |
| Torrent Pharmaceuticals | Bullish | 4,420.05 | -0.13 | 1,48,776.76 | 67.32 | 17.1 | 0.83 | 17.62 |
| Divi's Laboratories | Bearish | 6,332.00 | -0.62 | 1,68,063.05 | 78.61 | 11.52 | 0.46 | 0.01 |
- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2026-02-06 | Quarterly Results |
| 2025-11-13 | Quarterly Results |
| 2025-08-13 | Quarterly Results |
| 2025-05-26 | Audited Results & Final Dividend |
| 2025-02-10 | Quarterly Results |
- IndustryBiotechnology & Drugs
- ISININE790G01031
- BSE Code530549
- NSE CodeSHILPAMED
Shilpa Medicare is trading at 337.30 as on Wed Mar 11 2026 09:59:43. This is -0.49% lower as compared to its previous closing price of 338.95.
The market capitalization of Shilpa Medicare is 6622.38 Cr as on Wed Mar 11 2026 09:59:43.
The average broker rating on Shilpa Medicare is Strong Buy. The breakup of analyst rating is given below -
- 2 analysts have given a strong buy rating
- 0.00 analysts have given a buy rating
- 0.00 analysts have given a hold rating
- 0.00 analysts have given a sell rating
- 0.00 analysts have given a strong sell rating
The 52 wk high for Shilpa Medicare is 501.60 whereas the 52 wk low is 260.00
Shilpa Medicare can be analyzed on the following key metrics -
- TTM P/E: 41.43
- Sector P/E: 23.45
- Dividend Yield: 0.15%
- D/E ratio: -
Shilpa Medicare reported a net profit of 78.29 Cr in 2025.
The Mutual Fund Shareholding was 5.20% at the end of 31 Dec 2025.